Company intelligence / Profile preview

Fluo Labs

San Marcos, California, United States

Ownership: Private
Development stage: Other

Overview

Fluo Labs is developing an investigational, over-the-counter, handheld intranasal light therapy device intended to relieve symptoms of allergic rhinitis by using photobiomodulation to inhibit histamine release and reduce nasal inflammation; it has completed proof-of-concept studies and is planning/undertaking pivotal clinical trials to support an FDA De Novo submission and CE marking.[2][3][7]

Therapeutic areas: Immunology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

P&G Ventures (2021 CES Innovation Challenge finalist relationship)[2]

Beyond the preview

Go deeper on Fluo Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fluo Labs.

Explore the full profile